EDWARDS LIFESCIENCES/ US28176E1082 /
| 2024-11-12 7:31:04 PM | Chg. -1.33 | Volume | Bid8:04:22 PM | Ask8:04:22 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 61.25EUR | -2.13% | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 36.43 bill.EUR | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 2.31 USD | -6.10% |
| EPS Diluted: | 2.30 USD | -5.74% |
| Revenues per Share: | 9.99 USD | 12.86% |
| Book Value per Share: | 11.17 USD | 17.07% |
| Cash Flow per Share: | 1.49 USD | -25.61% |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 6,004.80 USD | 11.56% |
| Net Income: | 1,402.40 USD | -7.85% |
| Operating Cash Flow: | 895.80 USD | - |
| Cash and Cash Equivalents: | 1,144.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 28.49 | 33.01 |
| P/S Ratio: | 6.59 | 7.64 |
| P/BV ratio: | 5.89 | 6.82 |
| P/CF Ratio: | 44.17 | 51.18 |
| PEG: | -4.67 | -5.41 |
| Earnings Yield: | 3.51% | 3.03% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 36.43 bill. EUR | 41.53 bill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | - EUR | - EUR |
| Shares Outstanding: | 602.4 mill. | |
Profitability
| Gross Profit Margin: | 77.02% |
| EBIT Margin: | 25.55% |
| Net Profit Margin: | 23.35% |
| Return on Equity: | 20.87% |
| Return on Assets: | 14.98% |
Financial Strength
| Liquidity I / Cash Ratio: | 95.70% |
| Liquidity II / Quick Ratio: | 160.54% |
| Liquidity III / Current Ratio: | 337.60% |
| Debt / Equity Ratio: | 39.35% |
| Dynam. Debt / Equity Ratio: | 295.13% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
